Reports
-
COVID-19 Had a Devastating Impact on Medicare Beneficiaries in Nursing Homes During 2020
-
Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2019 Average Sales Prices
-
California Did Not Ensure That Nursing Facilities Always Reported Incidents of Potential Abuse or Neglect of Medicaid Beneficiaries and Did Not Always Prioritize Allegations Properly
-
Medicare Hospice Provider Compliance Audit: Professional Healthcare at Home, LLC
-
Opportunities Exist for CMS and Its Medicare Contractors To Strengthen Program Safeguards To Prevent and Detect Improper Payments for Drug Testing Services
-
University of Michigan Health System: Audit of Medicare Payments for Polysomnography Services
-
New Mexico Did Not Bill Manufacturers for Some Rebates for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations
-
Medicare Home Health Agency Provider Compliance Audit: Caretenders of Jacksonville, LLC
-
FY 2022 Congressional Budget Justification
-
Spring 2021 Semiannual Report to Congress
-
Medicare Made Millions of Dollars in Overpayments for End-Stage Renal Disease Monthly Capitation Payments
-
Medicare Advantage Compliance Audit of Specific Diagnosis Codes That Anthem Community Insurance Company, Inc. (Contract H3655) Submitted to CMS
-
Medicare Hospice Provider Compliance Audit: Franciscan Hospice
-
Advisory Opinion 21-05
-
Advisory Opinion 21-04
-
Medicare Hospice Provider Compliance Audit: Alive Hospice, Inc.
-
Medicare Hospice Provider Compliance Audit: Ambercare Hospice, Inc.
-
Advisory Opinion 21-03
-
U.S. Department of Health and Human Services Met Many Requirements, but It Did Not Fully Comply With the Payment Integrity Information Act of 2019 and Applicable Improper Payment Guidance for Fiscal Year 2020
-
CMS Needs to Strengthen Regulatory Requirements for Medicare Part B Outpatient Cardiac and Pulmonary Rehabilitation Services to Ensure Providers Fully Meet Coverage Requirements